picture of Merck will provide its Provantage development and manufacturing services to Y-mAbs Therapeutics

Merck to provide Provantage manufacturing services to Y-mAbs

Supporting Y-mAbs’ monoclonal antibody in late stage clinical development to treat paediatric brain cancer

Recommended

Subscribers

Sign in now to see personalised content appear here.

You can also see your reading history and subscription details on your subscriber page.

Why subscribe?
Find out more.

Sign up for your FREE email newsletter  +

New

Synpromics and GE Healthcare to extend the biologics production toolbox

January 4, 2017

Synpromics will develop a complex barcoded library of synthetic promoters, using its proprietar ...

R and D | Biotechnology | Finance

Could drug product safety improved through post-cured tubing?

December 14, 2016

A Watson Marlow Fluid Technology Group study shows biopharmaceutical drug efficacy, safety and ...

Europe | Biotechnology | Manufacturing and Equipment

HSPC-GT: meeting an industry challenge

January 9, 2017

How haematopoietic stem and progenitor cell gene therapy has gone from quagmire to saviour and ...

R and D | Biotechnology

TxCell Signs inlicensing agreement with Inserm Transfert for novel population of regulatory T cells

December 12, 2016

TxCell SA, a biotechnology company developing innovative, personalised cellular immunotherapies ...

Europe | R and D | Biotechnology

Puridify and GSK extend evaluation of FibroSelect purification technology

December 9, 2016

The technology is set to transform purification and reduce validation burden in bioprocess manu ...

Biotechnology

Can epi-drugs capture the next wave of growth?

December 19, 2016

An explosion in the field of epigenetics has revealed multiple ‘goldmines’ in the form of biolo ...

Ingredients | Biotechnology | Measurement and Analysis

Sartorius Stedim Biotech presents the first fully integrated upstream platform

December 7, 2016

Unique product and service portfolio extensively covers all steps from cell line development to ...

R and D | Biotechnology | Manufacturing and Equipment

Synthetic biology: engineering the future

December 12, 2016

That synthetic biology will become the next big engineering discipline in the 21st century is c ...

R and D | Biotechnology

Synpromics collaborates with Sartorius Stedim Cellca to develop improved biologicals manufacturing process using synthetic promoters

December 5, 2016

Synpromics, the leading synthetic promoter and gene control company, is pleased to announce a c ...

R and D | Biotechnology | Manufacturing and Equipment

Facilitating a revolution in medicine

December 6, 2016

The first-of-its-kind production facility for cell and gene therapy companies is being built in ...

Design and Build | Biotechnology

Merck expands distribution agreement with Roche

December 2, 2016

Merck to be the exclusive supplier of novel enzymes for polymerase chain reaction (PCR) and qua ...

Ingredients | Biotechnology | Finance | Measurement and Analysis

A new generation of ‘better biologics’

May 3, 2016

The growth of biologics has been rapid and new generation therapies are now using multiple ther ...

R and D | Biotechnology

In Brief